Discover a study that investigated how vedolizumab affects the immune cells circulating in the blood, focusing on which ...

As the science stands, the vast majority of the roughly eight million people in South Africa living with HIV will have to get ...

Highly effective treatments for HIV have existed since the mid-1990s. But while these treatments keep people healthy, we do not yet have a safe and scalable way to completely rid the body of the virus ...

and various CD4 + T cell subsets. This also suggests partial protection against HIV infection at the cellular level. Memory CD8 + T cells are the mature version that has encountered an antigen ...

and various CD4 + T cell subsets. This also suggests partial protection against HIV infection at the cellular level. VNPs had ...

Researchers identified a unique antibody signature against the Epstein-Barr virus protein EBNA1 that correlates with ...

Expansion of Phase 1 CALiPSO-1 trial of CNTY-101 in autoimmune disease to include diffuse cutaneous systemic sclerosis and idiopathic ...

In vitro CD4+ T-cell polarisation experiments were performed with T-cell activating CD2/CD3/CD28-coated beads in the absence or presence of pro-Th1 or pro-Th17 cytokines. CD1c+ DC and CD16+ macrophage ...

An additional and highly significant finding is that recruitment and activation of these T cell subsets by DPX was evident regardless ... and also delivers an innate immune activator and a universal ...